Glazer Capital’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
Other funds holding NRXP
Glazer Capital's NRXP Position: Q4 2020 in Review
Glazer Capital sold out of NRX Pharmaceuticals (NRXP) in Q4 2020, closing a stake of 6,698 shares — an estimated $718K sold.
Glazer Capital first reported a position in NRXP in Q4 2017 and held it in 7 quarters. The position peaked at $1.9M in Q2 2018. 6 funds tracked by Wall St. Rank hold NRXP as of Q4 2020.
- Glazer Capital reported no remaining NRX Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Glazer Capital sold 6,698 NRX Pharmaceuticals shares in Q4 2020, an estimated $718K.
- Glazer Capital first reported a position in NRX Pharmaceuticals in Q4 2017 and held it in 7 quarters.
- Glazer Capital's NRX Pharmaceuticals position peaked at $1.9M in Q2 2018.
- 6 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q4 2020.
Based on Glazer Capital's 13F filing for Q4 2020, filed 16 Feb 2021.